Search results
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 7 hours agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
20 Fastest Growing Health Tech Companies in the World
Insider Monkey via Yahoo Finance· 2 hours agoIn this article, we will be taking a look at the 20 fastest growing health tech companies in the...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 7 hours agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 4 hours agoSales of human papillomavirus vaccine Gardasil jumped 14% to $2.25 billion. That narrowly topped...
Op-Ed | Higher drug prices jeopardize the health of New Yorkers | amNewYork
amNewYork· 7 days agoIf you or your loved ones have had similar experiences at the pharmacy counter, it’s important you...
Will Higher Keytruda Sales Drive Merck's Q1
Forbes· 2 days agoMerck (NYSE: MRK) will report its Q1 2024 results on Thursday, April 25. As usual, Keytruda will be the driving growth for Merck with quarterly sales...
How Many More Ozempic-like Drugs Are In the Pipeline — Here’s What Researchers Are Working On
Inverse· 5 days agoFew drugs have achieved the stardom that semaglutide, marketed in the United States as Ozempic or...
Merck & Co., Inc. (MRK) Scheduled to Post Quarterly Earnings on Thursday
ETF DAILY NEWS· 3 days agoMerck & Co., Inc. (NYSE:MRK – Get Free Report) will announce its earnings results before the market opens on Thursday, April 25th. Analysts expect the company to announce earnings of $2.12 per ...